Results 241 to 250 of about 10,534,234 (296)

Increased vulnerability to low-density lipoprotein cholesterol in apolipoprotein E4-positive females: Longitudinal effects on neurodegeneration and cognition. [PDF]

J Alzheimers Dis
Tayem AJ, Jaber AB, Altantawi AM, Masadeh NM, Al Quran L, Al-Jammal O, Alzheimer's Disease Neuroimaging Initiative *.   +6 more
europepmc   +1 more source

Association Between Deep Gray Matter Iron Deposition Dysregulation and Cognitive Performance in Type 2 Diabetes Mellitus Patients: A Quantitative Susceptibility Mapping Study

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background Type 2 diabetes (T2DM) heightens cognitive impairment risk, yet the mechanisms remain unclear. Hyperglycemia‐induced iron dysregulation in deep gray matter (DGM) nuclei may be a crucial mechanism. Purpose To investigate DGM iron deposition in T2DM using Quantitative Susceptibility Mapping (QSM) and determine its association with ...
Kun Wang, Jiahe Wang, Ziyu Diao, Xin Tan, Shijun Qiu, Jie An   +5 more
wiley   +1 more source

Patients with type 1 diabetes mellitus and recommended low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B targets - a SwissDiab study. [PDF]

Front Endocrinol (Lausanne)
Liu C, Renström F, Gastaldi G, Brändle M, Bilz S.   +4 more
europepmc   +1 more source

Long‐Term Blood Pressure Variability, Hippocampal Subfield Volume and Cognitive Decline: A Population‐Based Prospective MRI Study

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background Long‐term blood pressure variability (BPV) is associated with cognitive decline, yet the underlying mechanisms have not been fully elucidated. Purpose To investigate the associations between long‐term BPV and hippocampal subfield volume and cognitive function and to assess the mediation effect of hippocampal subfield volume.
Fei Li, Jing Chen, Huijing Shi, Ling Yang, Xianyu Zhu, Rui Li, Xinyu Zhao, Xiaoliang Liang, Shun Zhang, Yaping Zhang, Han Lv, Jing Li, Shuohua Chen, Yuntao Wu, Ying Hui, Shouling Wu, Zhenchang Wang, Xiaoshuai Li   +17 more
wiley   +1 more source

Risk of end-stage renal disease in Korean patients with type 2 diabetes according to cumulative low-density lipoprotein cholesterol levels. [PDF]

J Diabetes Investig
Lee DY, Han KD, Ko JH, Jang HN, Moon SJ, Kwon HM, Park SE, Lee WY, Rhee EJ.   +8 more
europepmc   +1 more source

Comment on 'low-density lipoprotein cholesterol and clinical outcomes in patients with liver cirrhosis: a nationwide cohort study'. [PDF]

Ann Med
Chai Y, Xu T, Qiu S.
europepmc   +1 more source

Effect of Small Dense Low-Density Lipoprotein Cholesterol Combined With High-Sensitivity C-Reactive Protein on Cardiometabolic Multimorbidity: A National Cohort Study. [PDF]

Clin Cardiol
Guo Z, Shen J, Song F.
europepmc   +1 more source

Low-Density Lipoprotein Cholesterol Lowering With Inclisiran Plus Usual Care in Recent Acute Coronary Syndrome: VICTORION-INCEPTION, a Randomized, Controlled, Open-Label Trial. [PDF]

J Am Heart Assoc
Knowlton KU, Navar AM, Anderson JL, Brown AS, Muhlestein JB, Kleeman K, Sarwat S, Abbas CA, Ramirez MA, Grines CL, Abo-Auda WS, Desai NR.   +11 more
europepmc   +1 more source

Optimizing low-density lipoprotein cholesterol (LDL-C) management - a US physician survey of barriers and burdens. [PDF]

Am J Prev Cardiol
Leiter LA, Karmarkar T, Bash LD, Exter J, Schmier JK, Jayade SP, Roney KC, Simpson RJ, Baum SJ.   +8 more
europepmc   +1 more source

Low-Density Lipoprotein Cholesterol Is Independently Associated with White Matter Injury Beyond Coronary Artery Calcium: Insights into Brain Aging. [PDF]

J Clin Med
Çakır Ö, Açar B, Dönmez MK, Shatat A, Bünül SD, Erten R, Yalnız A, Çiftçi E.   +7 more
europepmc   +1 more source